What Is the Prolia Rebound Effect After Stopping Treatment?

If your Prolia (denosumab) injection is delayed, or if you stop taking it without starting another osteoporosis medicine, you are at risk for a severe rebound effect. This rebound involves a rapid loss of bone density and a highly increased risk of suffering multiple fractures in your spine ^[1]. Because of this risk, you should never take a “drug holiday” from Prolia without a medical plan in place.

What to Do If Your Injection Is Late or You Plan to Stop

The action you take depends on your situation, but you should never try to manage a transition on your own:

• If your dose is late: Contact your prescribing doctor immediately. Do not wait for pain or symptoms. Usually, a late injection is simply given as soon as possible ^[2]. Do not assume a delay is safe just because you feel fine.
• If you are planning to stop: You and your doctor must arrange a follow-on medication (a transition drug) timed around when your next Prolia dose would have been due—roughly six months after your last injection ^[3].

Understanding the Rebound Effect

Prolia works by blocking osteoclasts, the cells that naturally break down bone in your body. However, its effects are temporary and wear off about six months after an injection ^[2].

If you do not receive your next injection, those bone-clearing cells become highly active again. This causes a sudden surge in bone turnover, which is the process of old bone being removed ^[1]. This surge can begin roughly three to six months after your last injection, and bone turnover can soon exceed the levels you had before you ever started treatment ^[1]. As a result, the bone density you gained while on Prolia can be rapidly lost, with much of the loss occurring during the first year off the medication ^[1].

The Risk of Spine Fractures

The most dangerous consequence of this rapid bone loss is a severely increased risk of vertebral fractures (fractures of the bones in the spine) ^[4]. Because the bone weakens so quickly, these fractures can happen without any trauma or fall ^[5].

When fractures happen during this rebound phase, they often occur in clusters. In one major study of patients who stopped Prolia, the absolute risk of suffering multiple spine fractures was 3.4% ^[1]. Of the people in that study who did experience a spine fracture after stopping, about 60% suffered multiple fractures at the same time ^[1]. These fractures most commonly occur roughly 7 to 20 months after the last injection ^[6].

Your personal risk for these fractures is higher if:

• You have previously had a bone fracture ^[1]
• You have been on Prolia for a long time (for example, more than three years) ^[7]
• Your scheduled injection is substantially delayed ^[8]

Symptoms to Watch For: Spine fractures can sometimes happen silently, but you should contact your doctor promptly if you experience new, severe, or persistent back pain, a noticeable loss of height, or a newly stooped posture.

Transitioning to a Follow-on Medication

Because of the severe rebound effect, medical guidelines strongly recommend that Prolia should not be stopped without a follow-on antiresorptive medication ^[3][4].

Usually, this is a bisphosphonate, such as an intravenous infusion of zoledronic acid or oral alendronate. These drugs help lock in the bone density you gained. To be effective, this follow-on treatment is typically given around six months after your last Prolia injection ^[3][9].

However, these transition drugs are not interchangeable or suitable for everyone. Your doctor must consider your kidney function, calcium and vitamin D levels, and any gastrointestinal issues before choosing a drug ^[3]. Furthermore, follow-on medications significantly reduce the risk of rapid bone loss and fractures, but they do not guarantee complete protection, especially for patients who were on Prolia for many years ^[10].

Monitoring After Transition

Once you transition to a follow-on medication, your care team may monitor you closely during the first year off Prolia ^[11].

Your doctor might order specific blood tests to check your CTX levels (a bone turnover marker that estimates how fast your bone is breaking down) ^[12][13]. Depending on these test results, or follow-up bone density scans, your doctor might decide that you need an additional dose of a transition drug or an adjusted treatment plan ^[12].